Ahmed Salem MD, MBBCH, PGCert, MSc, PhD, FHEA, FESTRO, FRCR

Dr. Salem is an Assistant Professor in the Department of Medical Sciences, Hashemite University (primary affiliation; Zarqa, Jordan), honorary Senior Clinical Lecturer (equivalent rank in the US is associate professor) in Cancer Research at the University of Manchester (UK), and Consultant in Radiation Oncology in Khalidi Medical Plaza/ Afia Nuclear Medicine and Radiation Oncology Centre (Amman, Jordan).

Clinically specializing in radiation oncology, Dr. Salem’s research focuses on lung cancer, proton radiotherapy, MR Linac, novel trials, biomarkers, and hypoxia.

Dr. Salem completed training in radiation oncology at King Hussein Cancer Centre (Amman, Jordan) in 2014, attaining fellowships and specialty certifications in clinical (FRCR), radiation (ESTRO fellowship & Jordanian board), and medical oncology (MRCP medical oncology & ESMO certification). Dr. Salem also completed a CRUK/EPSRC-funded clinical research fellowship in 2017, attaining a Ph.D. from the University of Manchester for research focusing on non-invasive therapeutic lung cancer biomarkers.

Dr. Salem attained specialist registration in the UK in 2017 and worked as a clinical oncology consultant at the Christie Hospital till January 2022.

Dr. Salem has successfully delivered several world-class clinical/ translational studies on lung cancer patients, publishing more than 62 peer-reviewed papers and many abstracts, posters, and proceedings at eminent oncology conferences. Dr. Salem is a recipient of more than 10 prestigious academic oncology awards such as the ESTRO Accuracy Award and the ASTRO International-US annual meeting scientific Abstract award.